Sapana Supekar

  • Covid 19 Impact on Acute Hospital Care Market Trends, Sales, Supply, Demand, Analysis, Share

    Market Research Future (MRFR) collected data on several factors including implications of COVID 19 Impact on Acute Hospital Care Market and demographic challenges, showed how it could move forward in the coming years.

    Acute Hospital Care Market Analysis 

    The acute hospital care market is projected to grow at a 7.8% CAGR between 2017-2023, reveals the new Market Research Future (MRFR) report. Acute care, simply put, is secondary health care where patients are offered short term treatment for different medical conditions like recovery from surgery and severe injury. It is generally offered to patients through healthcare experts, including surgical and medical specialties. Emergency department, cardiology, neonatal intensive care, intensive care, and coronary care are the different acute hospital care services.  

    Numerous factors are adding to the acute hospital care market demand. Such factors, as revealed by the latest MRFR report, include rising number of elderly people having acute diseases, unmet medical needs, the rise in the number of hospitals, rising prevalence of trauma injury, favorable reimbursement through Medicaid and Medicare, and rising inpatient volume in hospitals. Additional factors adding market growth include increasing incidence of chronic diseases and hospitals actively working to reduce the turnaround time and length of stay.  

    On the contrary, the limited availability of equipment and facilities may limit the acute hospital care market growth over the forecast period.  

    Acute Hospital Care Market Key Players 

    Key players profiled in the acute hospital care market report include National HealthCare Corp (US), PruittHealth (US), Kindred Healthcare, Inc. (US), Ardent Health Services (US), Vanguard Health System Inc. (US), Tenet Healthcare Corp. (US), Universal Health Services, Inc. (US), Community Health Systems LLC (US), HCA Holdings, Inc. (US), among others. 

    Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/4931 

    Acute Hospital Care Industry News 

    March 2020: The YMCA is offering emergency child care to help fight coronavirus. Child care will be for children aged between 5-12 years in grades K-8, and the capacity per site will be 25 children. 

    Acute Hospital Care Market Segmentation 

    The Market Research Future Report provides an inclusive segmental analysis of the acute hospital care market based on services and medical condition.  

    By medical condition, the acute hospital care market is segmented into acute care surgery, trauma care, critical care, pre-hospital care, short-term stabilization, urgent care, and emergency care. Of these, emergency care will lead the market over the forecast period for the availability of Medicare reimbursement and Medicaid, rising prevalence of cardiovascular diseases, increasing burden of burn cases and trauma injuries, and rising incidence of communicable diseases. 

    By services, the acute hospital care market is segmented into emergency department, cardiology, neonatal intensive care, intensive care, and coronary care. Of these, the intensive care segment will dominate the market over the forecast period for the rising number of patients seeking intensive monitoring as well as nursing 24/7.  

    Acute Hospital Care Market Regional Analysis 

    By region, the global acute hospital care market covers the growth opportunities and recent trends across Europe, the Americas, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will have the lions share in the market during the forecast period. Factors adding to the acute hospital care market growth in the region include the concentration of key companies, increased research and development activities, rising government support for R&D, high health care expenditure, increasing patient population, and well-developed technology.  

    The acute hospital care market in Europe will hold the second-largest share during the forecast period for the accessibility of funds for research and ample support from the government for R&D. France & Germany are the major contributors in the region as they are laying more emphasis on hospital infrastructure and rising investment in healthcare. 

    The acute hospital care market in the APAC region is predicted to grow at a quick pace over the forecast period. Factors adding to the acute hospital care market growth in the region include high healthcare expenditure, a huge patient population, and rapidly developing healthcare technology. Growing demand for quality healthcare devices and burgeoning demand for such hospital care in South Korea and India are also adding market growth.  

    The acute hospital care market in the MEA is predicted to have a small share during the forecast period for deprived political conditions, especially in Africa, limited medical facilities, and less accessibility of funds.   

    Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/acute-hospital-care-market-4931


  • Covid 19 Impact on Acute Hospital Care Market Trends, Sales, Supply, Demand, Analysis, Share

    Market Research Future (MRFR) collected data on several factors including implications of COVID 19 Impact on Acute Hospital Care Market and demographic challenges, showed how it could move forward in the coming years.

    Acute Hospital Care Market Analysis 

    The acute hospital care market is projected to grow at a 7.8% CAGR between 2017-2023, reveals the new Market Research Future (MRFR) report. Acute care, simply put, is secondary health care where patients are offered short term treatment for different medical conditions like recovery from surgery and severe injury. It is generally offered to patients through healthcare experts, including surgical and medical specialties. Emergency department, cardiology, neonatal intensive care, intensive care, and coronary care are the different acute hospital care services.  

    Numerous factors are adding to the acute hospital care market demand. Such factors, as revealed by the latest MRFR report, include rising number of elderly people having acute diseases, unmet medical needs, the rise in the number of hospitals, rising prevalence of trauma injury, favorable reimbursement through Medicaid and Medicare, and rising inpatient volume in hospitals. Additional factors adding market growth include increasing incidence of chronic diseases and hospitals actively working to reduce the turnaround time and length of stay.  

    On the contrary, the limited availability of equipment and facilities may limit the acute hospital care market growth over the forecast period.  

    Acute Hospital Care Market Key Players 

    Key players profiled in the acute hospital care market report include National HealthCare Corp (US), PruittHealth (US), Kindred Healthcare, Inc. (US), Ardent Health Services (US), Vanguard Health System Inc. (US), Tenet Healthcare Corp. (US), Universal Health Services, Inc. (US), Community Health Systems LLC (US), HCA Holdings, Inc. (US), among others. 

    Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/4931 

    Acute Hospital Care Industry News 

    March 2020: The YMCA is offering emergency child care to help fight coronavirus. Child care will be for children aged between 5-12 years in grades K-8, and the capacity per site will be 25 children. 

    Acute Hospital Care Market Segmentation 

    The Market Research Future Report provides an inclusive segmental analysis of the acute hospital care market based on services and medical condition.  

    By medical condition, the acute hospital care market is segmented into acute care surgery, trauma care, critical care, pre-hospital care, short-term stabilization, urgent care, and emergency care. Of these, emergency care will lead the market over the forecast period for the availability of Medicare reimbursement and Medicaid, rising prevalence of cardiovascular diseases, increasing burden of burn cases and trauma injuries, and rising incidence of communicable diseases. 

    By services, the acute hospital care market is segmented into emergency department, cardiology, neonatal intensive care, intensive care, and coronary care. Of these, the intensive care segment will dominate the market over the forecast period for the rising number of patients seeking intensive monitoring as well as nursing 24/7.  

    Acute Hospital Care Market Regional Analysis 

    By region, the global acute hospital care market covers the growth opportunities and recent trends across Europe, the Americas, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will have the lions share in the market during the forecast period. Factors adding to the acute hospital care market growth in the region include the concentration of key companies, increased research and development activities, rising government support for R&D, high health care expenditure, increasing patient population, and well-developed technology.  

    The acute hospital care market in Europe will hold the second-largest share during the forecast period for the accessibility of funds for research and ample support from the government for R&D. France & Germany are the major contributors in the region as they are laying more emphasis on hospital infrastructure and rising investment in healthcare. 

    The acute hospital care market in the APAC region is predicted to grow at a quick pace over the forecast period. Factors adding to the acute hospital care market growth in the region include high healthcare expenditure, a huge patient population, and rapidly developing healthcare technology. Growing demand for quality healthcare devices and burgeoning demand for such hospital care in South Korea and India are also adding market growth.  

    The acute hospital care market in the MEA is predicted to have a small share during the forecast period for deprived political conditions, especially in Africa, limited medical facilities, and less accessibility of funds.   

    Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/acute-hospital-care-market-4931


  • COVID 19 Analysis: Chlorhexidine Gluconate (CHG) Wipes Market - Size, Trends, Growth, Share

    Chlorhexidine Gluconate Wipes Market Overview:

    Global Chlorhexidine Gluconate (CHG) Wipes Market has the backup to record a CAGR of 4.40% during the forecast period of 2018 to 2023 to reach USD 13948.89 thousand. These CHG wipes are antiseptic wipes with high amount of Chlorhexidine Gluconate (CHG) mixed in it. The process is to ensure better removal of bacteria and prevention of various infection. Market Research Future (MRFR) has focused well on the Chlorhexidine Gluconate Wipes Market and declared that this growth can be attributed to several factors of which hike in healthcare investment is expected to make better market growth.

    Various clinics and hospitals are launching substantial demand for the CHG Wipes Market due to the global implementation of stringent laws to protect patients from various infections.

    Chlorhexidine Gluconate Wipes Market Competitive Landscape:

    Several companies are making substantial changes in the global CHG Wipes Market. These companies try to initiate various moves that can influence personal growth and ensure cementing of their market presence. At the same time, these would also take the market forward by substantial margin. These companies are various 3M (US), Becton, Dickinson and Company (US), GAMA Healthcare Ltd (UK), Cardinal Health (US), PDI Limited (US), Carenow Medical Pvt. Ltd. (India), Pal International (UK), Lernapharm Inc. (Canada), and others. MRFR’s attempt to record their moves is to ensure better market understanding that would highlight trends suitable for the coming years.

    Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/7564

    Chlorhexidine Gluconate Wipes Market Segmentation:

    Global CHG wipes market, upon a consideration of various segments, reveals product type, CHG concentration, application, and distribution channel. These segments portray factors with greater details and open up possibilities of the market understanding.

    By product type, Chlorhexidine Gluconate (CHG) Wipes Market Report can be segmented into CHG bath wipes and CHG/alcohol-based wipes.

    By CHG concentration, the market for for Chlorhexidine Gluconate (CHG) Wipes includes into 2% and 0.5%.

    By application, the global CHG wipes market research includes catheter-associated urinary tract infections, central line-associated bloodstream infection, surgical site infection, and lens cleaners.

    By distribution channel, the for CHG Wipes Market encompasses hospitals & retail pharmacies and online platforms. The hospital and retail pharmacies segment had a valuation of USD 6,407.63 thousand in 2017.

    Chlorhexidine Gluconate Wipes Market Regional Analysis:

    Global CHG Wipes Market Trends, based on a detailed segmentation by MRFR, includes regions like the Americas, Europe, and APAC (Asia-Pacific) where the growth possibility for the market is quite substantial. In the Middle East and Africa region this growth would be a bit slackening due to the presence of several poor economies.

    The Americas can expect substantial growth for the global CHG Wipes market as the healthcare sector in the region is quite extensive and invites high investment. The market gets ample backups from the increase in number of patients who undergo surgical procedure. Disposable income of patients can also inspire better market possibilities. The increasing inclusion of well-developed technology can substantially push the regional market forward. The market has North America and South America of which the North part is performing well.

    Europe market is following the lead of the APAC region and their high healthcare expenditure is boosting the research and development sector. At the same time, CHG Wipes market growth can be backed by the presence of several market players who are devising diverse strategies to gain lead from the market.

    The APAC market can benefit from the changing healthcare sectors in various countries. The high number of patient population in the region can ensure hike in the number of patient population. This region is also the fastest-growing region. Countries like Australia, India, China, Japan, and others are expected to experience substantial growth in the market.

    Obtain Premium Research Report Details considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/chlorhexidine-gluconate-wipes-market-7564

    Chlorhexidine Gluconate (CHG) Wipes Industry news

    In February 2019, Medline announced a new procedure using which various hospitals and surgical centers can prepare their patients for operations. This pre-operative measure includes patient skin where standardized procedures ensure reduction of surgical site infections (SSIs). The company launched a new FDA-approved ReadyPrepTM CHG cloth. These clothes are pre-saturated and it contains 2 % chlorhexidine gluconate. This is an antiseptic that has the ability to remove infection-causing bacteria.

     


  • COVID 19 Analysis: Veterinary Equipment and Disposables Market Share, Global Overview

    Veterinary Equipment and Disposables Market Overview:

    The global market report covering veterinary equipment and disposables market stands at a position where the growth with a CAGR of 14.70% is possible and it would help in the market in achieving a valuation of USD 1.63 billion between 2018 and 2023. Market Research Future (MRFR) takes this time period as the forecast period for the market and studies all the details accordingly.

    The global market has high growth potential as the surge in the zoonotic diseases is raising eyebrows. Funds are getting channeled to ensure that research and development mark better growth. It is also getting traction from the increasing number of pet insurance that is providing people with better opportunities to treat their pets. In addition, various animal welfare organizations are launching in campaigns to ensure a better growth rate for the market. Current players have formed several strategies and it is also witnessing the boons of new entrants as the market is becoming competitive.

    Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/7398

    Veterinary Equipment and Disposables Market Segmentation

    The global market report on the veterinary equipment and disposables can find a better scope for understanding with proper segmentation. These segments are animal type, type, and end user.

    By type, the global market for veterinary equipment and disposables can be segmented into anesthesia equipment, critical care consumables, research equipment, temperature management equipment, fluid management equipment, and rescue & resuscitation equipment. The critical care consumables segment encompasses gastroenterology consumables, wound management consumables, airway management consumables, fluid administration & therapy consumables, needles, and others. The anesthesia equipment segment comprises ventilators, gas delivery management systems, anesthesia machines, waste gas management systems, vaporizers, and others. The research equipment segment includes lab evacuation systems and induction chambers. The rescue and resuscitation equipment segment covers resuscitation bags and oxygen masks.

    By animal type, the global market for veterinary equipment and disposables can be segmented into small animals and large animals.

    By end user, the global market report on the veterinary equipment and disposables envelops research institutes, veterinary hospitals, veterinary clinics, and others.

    Veterinary Equipment and Disposables Market Regional Analysis

    The market in the Americas has a better chance to dominate the global market for veterinary equipment and disposables. This is due to better structural provisions, high expenditure for research & development, increasing innovation, rising per capita income, and others. Several countries like the US and Canada are going to promote growth. These two countries are known for their superlative market presence and can inspire better growth.

    Europe would likely retain its second position in the global market for veterinary equipment and disposables. This regional growth would depend much on the healthcare system and better provision for the insurance coverage for pets. The rise in the number of doctors for these pets is also rising, which can provide better growth opportunities for the market. In the Asia Pacific region, the global market for veterinary equipment and disposables can find a significant rise from the propelling effect of the Indian market. The regional market would be the fastest in terms of growth. Various animal welfare organizations are playing in favor of the market, which can promote growth. The Middle East & Africa (MEA) can find better growth opportunities as the number of pet owners is rising in the region.

    Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/veterinary-equipment-and-disposables-market-7398

    Veterinary Equipment and Disposables Market Competitive Landscape:

    The global market for veterinary equipment and disposables market can be taken into consideration with an assessment of various market players. MRFR has included this to get a comprehensive picture of the entire market and understand how the market is going to shape up in the coming years. These companies are DRE Medical, B. Braun Melsungen AG, Henry Schein, Digicare Biomedical Technology Inc., Medtronic, Midmark Corporation, Jorgensen Labs, Smiths Group plc, Patterson Companies, Inc., and Vetland Medical Sales & Services. Extensive steps like mergers, acquisitions, tie-ups, and others can inspire better growth for the market.


  • COVID 19 Analysis: Medical Bionic Implant/Artificial Organs Market Analysis 2020: Key Findings

    Medical Bionic Implant/Artificial Organs Market Overview

    A bionic implant is an artificially engineered device that is implanted to replace a natural organ in a human, with the purpose to provide life support while awaiting a transplant and improves a patient's ability to interact socially.

    According to the report published by Market Research Future (MRFR), the medical bionic implant/artificial organs market is anticipated to grow exponentially and register a CAGR of 7.0% over the forecast period of 2018 to 2023.

    The growing cases of organ failure have improved the demand for replaceable organs, which contributes to the market growth of the medical bionic implant/artificial organs market to a great extent. The prevalence of organ failure is found to be more common among the elderly consumers, as they are more vulnerable towards health issues such as gastrointestinal problems, ophthalmic diseases, cancer, orthopedic diseases, among others. Other influential factors such as technological advancements, a growing number of accidents and injuries, improving the government regulatory framework and assistance, and the increasing prevalence of eye diseases are constantly contributing to create growth in the global medical bionic implant/artificial organs market.

    Despite these positive factors, issues connected with the medical bionic implant/artificial organs market are lack of skilled professionals, the high expenditure on devices, risk of malfunction of devices, and the comparatively poor healthcare system in low and middle-income countries may obstruct the growth of the market to an extent.

    Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/6051

    Medical Bionic Implant/Artificial Organs Market Segmental Analysis

    The market for global medical bionic implant/artificial organs is segmented by technology, product, fixation, end-user, and region.

    Based on technology, the market is bifurcated as mechanical bionics and electronic bionics.

    Based on the product, the market is classified as vision bionics, orthopedic bionics, ear bionics, neural/brain bionics, heart bionics, and others. Vision bionics is sub-segmented as bionic eye and others. Ear bionics are further segmented as Bone Anchored Hearing Aid (BAHA) and cochlear implant. Orthopedic bionics is sub-segmented as an exoskeleton, bionic leg, bionic hand, bionic finger, and electrical bone growth stimulators. The sub-segments of the bionic leg include bionic knee and bionic feet. electrical bone growth stimulators are sub-segmented into invasive bone growth stimulators and non-invasive bone growth stimulators. Heart bionics is sub-segmented as a total artificial heart, pacemaker, ventricular assist device, an artificial heart valve. The sub-segments of a pacemaker include implantable cardiac pacemaker and external pacemaker. The sub-segments of the artificial heart valve include a tissue heart valve and mechanical heart valve. Neural/brain bionics is sub-segmented as vagus nerve stimulators, deep brain stimulators, and spinal cord stimulators.

    By fixation, the market is bifurcated into implantable and externally worn.

    By end-user, the market has been segmented into research and academic institutes, hospitals and clinics, and others.

    Medical Bionic Implant/Artificial Organs Market Regional Analysis

    North America dominates the regional market for medical bionic implant/artificial organs due to the presence of major market players who have introduced advanced medical bionic implants.

    Europe is the second largest region in the global medical bionic implant/artificial organs market, owing to the government aid towards research and development expenditure, and the rising cases of organ failure and connected difficulties, and are expected to drive the European market.

    The Asia Pacific is assessed as the fastest growing medical bionic implant/artificial organs market owing to increasing demand for advanced treatments, a huge patient pool, and development in the healthcare technology. Healthcare expenditure is found to be improving in various Asia Pacific regions.

    The Middle East & Africa hold the lowest share of the global market due to low development, poor medical facilities, and lack of technical knowledge.

    Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/medical-bionic-implant-artificial-organs-market-6051

    Medical Bionic Implant/Artificial Organs Market Key Players

    The key market players in the global medical bionic implant/artificial organs market are, Biomet, Inc. (U.S.), NeuroPace, Inc. (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical, Inc. (U.S.)Cyberonics, Inc. (U.S.), Medtronic, Inc. (U.S.), Ekso Bionics (U.S.), Second Sight Medical Products, Inc. (U.S.), Aleva Neurotherapeutics SA (Switzerland), LivaNova PLC (U.K), Orthofix International N.V. (The Netherlands), Ossur (Iceland), Biocontrol Medical (Israel), and Cochlear Ltd. (Australia).


  • COVID 19 Analysis: Dental Consumables Market Report 2020 Key Company Profiles And Industry Size

    Dental Consumables Market Overview

    Dental consumables are products used by dental practitioners on patients to perform procedures related to preventive, restorative, diagnostic, and emergency dental issues. The dental consumables industry in North America is prognosticated to witness catapulting growth during the forecast period, as per the latest MRFR report. The Market Research Future (MRFR) report has mentioned that the North America dental consumables market is likely to expand at 6% CAGR, garnering a market revenue of USD 5,290.9 million during the assessment period. Many factors are underwriting to the growth of the global dental consumables market. One of the primary market drivers includes the comprehensive advancements made in the application of dentistry techniques by many professional dental professionals across the region.

    Furthermore, rapid population growth in America has consistently contributed to the upscaling of the North American dental consumables market. Various repairs and preventive care measures associated with the oral health of the population in North America has contributed majorly to the augmentation of the dental consumables market. According to the American Dental Association, 52.3% adults reported that they visited the dentist every six months, 15.4% visited once a year, and 11% visited every 2 to 3 years, in 2014. These statistics further support the prediction that the dentistry market is ever growing.

    Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/1806

    Other factors propelling the dental consumables market in North America to also include the prevalence of dental illnesses, rising number of dental procedures and the increasing geriatric population. Additionally, increasing government support towards research & development, mounting healthcare expenditure, and technological developments have pushed the North America dental consumables market to a great extent. However, inadequate reimbursement policies and the grey dental distribution market are likely to hinder the dental consumables market growth in the forecast period.

    Dental Consumables Market Segmentation

    The North America dental consumables market has been segmented on the basis of type. The segments based on type include dental prosthetics, dental restorative materials, dental implants, and dental regenerative material. The dental implants segment ruled the North America market in 2016 and is estimated to exhibit the fastest growth during the review period. The dental implants segment expected to reach a market valuation of USD 2,103.9 million by the end of 2023.

    Dental Consumables Market Regional Analysis

    In North America, the U.S. is estimated to grow at a significant rate owing to a mounting expenditure on healthcare. Further, rapid adoption of the latest products in the U.S. is expected to drive the dental consumables market in the region. High concentration of healthcare companies in the developed countries in the region, along with mushrooming insurance penetration are also likely to fuel exponential market growth in North America. The U.S. is anticipated to spearhead the North America dental consumables market, reaching a revenue valuation of USD 1,570 million by the end of the forecast period of 2017-2023. Such growth in the country can be attributed to a highly health-conscious population residing in the region. Also, growing geriatric population, proliferating number of dental procedures and rising prevalence of dental diseases due to poor oral hygiene are significant contributors to the substantial growth of the dental consumables market in the U.S.

    Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/dental-consumables-market-1806

    Dental Consumables Market Key Players

    The North America dental consumables market boasts the presence of numerous noteworthy players that are influencing the growth curve in the forecast period. These market players have been profiled in the latest report published by Market Research Future (MRFR). Some of these vendors include Institut Straumann AG, Henry Schein, Inc, Patterson Dental Supply, Inc., Dentsply Sirona, Kerr Corporation, Danaher Corporation, GC orthodontics, Planmeca Oy, and American Orthodontics.

     


  • COVID 19 Analysis: Aortic Aneurysm Market Size, Share Key Findings And Regional Analysis

    Aortic Aneurysm Market Overview

    Global aortic aneurysm market was analyzed by Market Research Future (MRFR) and it was projected that a notable CAGR of 8.4% will be attained by the market over the forecast period of 2018 to 2023. The valuation of the market was further stated to surpass its previous valuation USD 2,357.6 million in 2017 by the end of the forecast period.

    The global market is growing due to factors like increasing penetration of tobacco smoking in both developing as well as developed countries, growing elderly population across the globe, supportive reimbursement scenarios for surgical treatment of aortic aneurysms, the increasing prevalence of cardiovascular diseases, and rising technological advancements in products. On the other hand, the low reimbursement rates present in developing nations and high pricing level of aortic aneurysm treatment and devices can hinder the market growth in the next few years.

    Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/7776

    Aortic Aneurysm Market Segmentation

    The global aortic aneurysm market has been segmented in terms of type, end-user, treatment, and product.

    By product, the market divides into catheters, stent-grafts, and others.

    By treatment, the market includes open surgical repair (OSR) and endovascular aneurysm repair (EVAR).

    By end-user, the market segments into ambulatory surgery centers (ASCs), hospitals and clinics, and others.

    By type, the market comprises thoracic aortic aneurysm (TAA) and abdominal aortic aneurysm (AAA). The abdominal aortic aneurysm (AAA) segment is expected to account for the maximum share percentage of the global market during the forecast period. This is because of the increasing prevalence of the disease which occurs primarily in the lower abdominal area.

    Aortic Aneurysm Market Regional Analysis

    The global aortic aneurysm market is geographically distributed across the following key regions: Asia Pacific, Americas, Europe, and the Rest of the World (RoW).

    The Americas is expected to continue its dominance of the aortic aneurysm market during the forecast period. This is attributed to the presence of major market vendors, established medical and healthcare infrastructure and facilities, increasing spending level in the healthcare industry, and consistent launches of novel devices across developed nations like the US and Canada.

    Europe is said to be the second-largest contributor to the global market of aortic aneurysm due to the massive prevalence of tobacco smoking herein and the number of favorable initiatives by several organizations to curb down the burden of aortic aneurysm. To paint a better picture, the World Health Organization (WHO) said that at present, Europe holds the highest prevalence of tobacco smoking amongst adult citizens (28%) and even some of the highest prevalence of tobacco use by adolescents.

    Asia-Pacific is most likely to experience the fastest growth in the aortic aneurysm market during the assessment period. This is because of the growing geriatric population herein and the booming prevalence of cardiovascular diseases & hypertension diseases, widespread awareness about aortic aneurysm treatment, and the developing healthcare infrastructure across key nations like India, China, and Australia. For instance, WHO reported recently that over one million people in the Western Pacific Region succumb to death each year from cardiovascular diseases, one which is caused due to the use of tobacco.

    The Middle East & Africa holds the minimal share in the global market. Addition, the major share of the market is held by the Middle Eastern region. Several findings have indicated that aortic aneurysm is extremely rare in the Middle East and only a meagre population is threatened by the deadly aortic aneurysms annually in the Middle East region.

    Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/aortic-aneurysm-market-7776

    Aortic Aneurysm Market Competitive Landscape

    The global aortic aneurysm market comprises a host of key players. This includes names like Lombard Medical Limited, Microport Scientific Corporation, Medtronic PLC, MAQUET Holding B.V. & Co. KG, Terumo Medical Corporation, Cook Medical, W. L. Gore & Associates, Endologix, Inc., JO0TEC AG (CryoLife, Inc.), and Cardinal Health, Inc.


  • COVID 19 Analysis: Veterinary/Animal Vaccines Market Revenue Growth Predicted By 2025

    Veterinary/Animal Vaccines Market Overview

    According to the analysis of Market Research Future (MRFR), the global veterinary/animal vaccines market is slated to register a CAGR of 6.38% over the evaluation period (2019-2025). Several factors are likely to influence the market growth, and the global veterinary/animal vaccines market is anticipated to acquire a market valuation of 9910.59 million by 2025.

    The rising livestock populace and the growing prevalence of livestock diseases coupled with the increasing awareness regarding animal health are expected to impact the global veterinary/animal vaccines market significantly. The increasing adoption of companion animals is also an influential factor for market growth over the forecast period. Additionally, the continuous technological advancements in the healthcare sector and enhancement of veterinary vaccines, along with the rise in government initiatives, are also likely to create favorable growth conditions for the market over the review period. On the other hand, the high costs associated with the storage of veterinary vaccines are expected to hinder the growth of the veterinary/animal market over the assessment period.

    Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/2687

    Veterinary/Animal Vaccines Market Segmental Analysis

    The global veterinary/animal vaccines market is segmented based on type and technology. The several types of veterinary/animal vaccines available in the market are aquaculture vaccines, companion animal vaccines, livestock vaccines, porcine vaccines, and poultry vaccines. The livestock vaccines segment has been accounted for the largest market share in the global veterinary/animal vaccines market and is expected to retain its dominant value over the forecast period.
    The various technologies adopted in the global veterinary/animal vaccines market are inactivated vaccines, live attenuated vaccine, recombinant vaccines, and toxoid vaccines.

    Veterinary/Animal Vaccines Market Regional Analysis

    On the basis of region, the global veterinary/animal vaccines market is segmented into the Asia Pacific (APAC), the Americas, Europe, and the Middle East and Africa.

    The American region accounts for the largest share of the global veterinary/animal vaccines market and is anticipated to retain its lead over the review period. The is attributed to the increasing adoption of pets, rising livestock population, and diseases prevalence.
    Europe is a significant region in the global market for veterinary vaccines and is expected to witness considerable growth over the assessment period, owing to the technological advancements taking place towards veterinary vaccines. The growth of the government and private sector of the healthcare industry in the region is also expected to contribute substantially to market growth.
    The Asia Pacific is assessed as the fastest-growing region of the global veterinary/animal vaccines over the evaluation period. This is credited to the increasing penetration of the veterinary sector in the region, rising numbers of private veterinary clinics, growth in consumer awareness regarding animal welfare, and the increasing effort of non-governmental organizations (NGOs) towards animal welfare.
    The middle east and African region are expected to account for the smallest market share over the review period. This can be attributed to the weak healthcare sector in the region, lack of skilled workforce, and the increasing political unrest in some parts of the middle east and Africa. The market in the region is expected to exhibit slow growth over the review period owing to the increasing government initiatives in Africa to improve the healthcare sector and the growing awareness of animal welfare in middle eastern countries.

    Veterinary/Animal Vaccines Market Key Players

    The key market players operating in the global veterinary/animal vaccines market by MRFR include Boehringer Ingelheim International GmbH (Germany), Biogenesis Bago SA (Argentina), Ceva (US), Elanco (US), Hipra (Spain), IDT Biologika GmbH (Germany), MSD & Co. Inc (US), Phibro Animal Health Corporation (US), Virbac (France), Zoetis (US), and others.

    Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/veterinary-animal-vaccines-market-2687

    Veterinary/Animal Vaccines Industry News

    July 2019 – The Colorado State University (CSU) announced a partnership of USD 9.5 million with the Coalition for Epidemic Preparedness Innovations (CEPI), an alliance that is aiming at disrupting epidemics, towards the development of a single-dose vaccine for rift valley fever (RFV) for humans.

    July 2019 – The National Institutes of Health (NIH), a renowned medical research center in the US, accorded an approximately USD 1.9 million grant to Zhilong Yang, an assistant professor in the Division of Biology towards his research project on developing human and animal vaccines with the use of vaccinia virus.


  • COVID 19 Analysis: Cranial Fixation and Stabilization Market Size, Industry Trends, Revenue

    Cranial Fixation and Stabilization Market Overview

    Craniotomy procedures are used to open up a bone flap in the skull to expose the brain. Cranial fixation systems are designed to ensure the stability of flaps during such procedures. They can reduce the surgical time and ensure the strength of flaps. Cranial stabilization systems are required during neurosurgeries and driven by high prevalence of neurological disorders. The global cranial fixation and stabilization market report by Market Research Future (MRFR) contains historical data, current trends, and future opportunities for the forecast period (2019-2025).

    Cranial Fixation and Stabilization Market Scope

    The global cranial fixation and stabilization market is predicted to touch a value of USD 2.29 billion by 2025. It can exhibit a CAGR of 8.90% during the forecast period owing to all surgical procedures involving the head. Rise of minimally invasive surgeries and breakthroughs in instruments demanded for surgeries can bode well for the market. According to the WHO, close to 6.8 million die of neurological conditions annually.

    Development of new surgical techniques to assist patients with neurological disorders and the largescale spending on healthcare by nations can be beneficial to the global cranial fixation and stabilization market. Establishment of standards and practices as well as the need for head and neck stabilization during surgeries can evoke the need for cranial fixation & stabilization systems.

    Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/8163

    However, strict regulations on cranial fixation and stabilization equipment and differing regulations on imports and exports of equipment can hamper the market growth.

    Cranial Fixation and Stabilization Market Segmentation

    The global cranial fixation and stabilization market is segmented by category, product, type, and end-user.

    Category-wise, the market is segmented into cranial stabilization systems and cranial fixation systems. Cranial fixation systems are used for fastening bones after fractures, fastening the skin to bones for trauma victims, and ensuring success in post-surgery. Large number of trauma cases which require the use of these equipment can drive global market growth. On the other hand, cranial stabilization systems can stabilize the head during invasive procedures.

    Products in the market include plates, flat tube clamps, skull clamps, meshes, screws, horseshoe headrests, and accessories. Meshes are used in reconstructive surgeries to fix the face. While skull clamps are used in holding the head firmly in place for surgery. Lastly, horseshoe headrests can support and stabilize the head so head movement is still possible.

    Types of cranial stabilization and fixation systems include resorbable and non-resorbable. Resorbable systems can account for a smaller share of the global cranial fixation and stabilization market due to being expensive in nature. While, the non-resorbable segment can generate revenue due to being economical in cost and being attached to the head in developing economies.

    End-users in the global cranial fixation and stabilization market are ambulatory surgical centers, hospitals, and others. Hospitals are likely to have the lead among the end-user segment till the end of the forecast period due to high volume of neurosurgeries being performed at these centers. While ambulatory surgical centers can also command a significant share of the market due to a large volume of trauma cases being treated at these facilities.

    Cranial Fixation and Stabilization Market Regional Analysis

    Europe, Americas, Asia Pacific (APAC), and the Middle East & Africa (MEA) are regions considered in the global cranial fixation and stabilization market.

    The Americas had led the global market, with the maximum share of the region belonging to North America. North America records a large number of trauma cases and brain-related injuries and can fuel the demand for cranial stabilization and fixation systems. On the flip side, APAC can register the highest growth rate during the forecast period due to large number of road accidents and investments by private players for improving the existing healthcare infrastructure.

    Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/cranial-fixation-stabilization-market-8163

    Cranial Fixation and Stabilization Market Competition Outlook

    Ostomed, Braun Melsungen AG, Zimmer Biomet, Medtronic, Changzhou Huida, Evonos, Stryker, Johnson & Johnson, DePuy Synthes, Pro Med Instruments, Integra LifeSciences Corporation, Medicon, Micromar, NEOS Surgery, KLS Martin Group, and Jeil Medical are prominent players in the global cranial fixation and stabilization market.


  • COVID 19 Analysis: Veterinary Laboratory Testing Market 2020, Growth Analysis, Share, Size

    Market Research Future (MRFR) collected data on several factors including implications of COVID 19 Impact on Veterinary Laboratory Testing Market and demographic challenges, showed how it could move forward in the coming years.

    Veterinary Laboratory Testing Market Overview

    Conferring to the report recently published by Market Research Future (MRFR), the Global veterinary laboratory testing market Size is expected to expand at a 10.1% CAGR over the forecast period. Veterinary laboratory testing is generally performed to diagnose the cause of the animal’s disease or disorder. The global veterinary laboratory testing market is witnessing fast-paced ascension owing to many significant factors.

    Increasing prevalence of zoonotic diseases is one of the primary factors driving the global veterinary laboratory testing market over the forecast period. As per the Maine Center for Disease Control and Prevention, approximately 75% of emerging infectious diseases affecting humans have an origin in animals. This is another factor driving the veterinary laboratory testing market exponentially.

    Furthermore, rising awareness of animal diseases and technological advancements in veterinary testing has pushed sizeable growth in the global veterinary laboratory testing market. Increasing expenditure towards pet insurance and favorable policies and funds introduced by governments across the globe are some of the factors causative of the ascension of the global veterinary laboratory testing market. Alternatively, a high cost of veterinary testing and different complications associated with these tests has hampered the augmentation of the global veterinary laboratory testing market.

    Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/7326

    Veterinary Laboratory Testing Market Segmentation

    The veterinary laboratory testing market has been studied for different segments on the basis of animal type, technology, products, end-user, and region. Based on products, the global veterinary laboratory testing market is segmented into instruments and consumables.

    Based on animal type, the global veterinary laboratory testing market is segmented into companion animal and livestock animal. The companion animal segment is sub-segmented into dogs, cats, and horses.  On the other hand, the livestock animal segment is further segmented into pigs, poultry, and cattle.

    On the basis of technology, the veterinary laboratory testing market is segmented into immunodiagnostics, biochemistry, molecular diagnostics, hematology, and urinalysis. The hematology segment is further segmented into hematology analyzers and hematology cartridges. The molecular diagnosis segment is further segmented into microarrays and polymerase chain reaction tests. The urinalysis segment is studied for the sub-segments of urine analyzers, urine test strips, and urinalysis clips & cartridges/panels.

    Based on end-users, the veterinary laboratory testing market is segmented into in-house testing, veterinary hospitals and clinics, research institutes, and diagnostic laboratories. The veterinary hospitals & clinics segment captured the largest share in the global veterinary laboratory testing market at the beginning of the forecast period. The segment is also assessed to witness substantial CAGR over the review period. This can be credited to the increasing prevalence of zoonotic diseases. Alternatively, the academic institutes segment is expected to showcase the fastest growth in the global veterinary laboratory testing market.

    Veterinary Laboratory Testing Market Regional Analysis

    The global veterinary laboratory testing market is regionally segmented into the Americas, Europe, Asia Pacific, and the Middle East & Africa. Among these segments, the veterinary laboratory testing market residing in the Americas is expected to spearhead the global market over the forecast period. Such market dominion can be owed to the increasing incidence of animal diseases and various technological advancements in veterinary diagnostics.

    Europe is estimated to follow the Americas and garner the second-largest share in the global veterinary laboratory testing market over the assessment period. The augmentation of Europe’s veterinary laboratory testing market is attributed to the rising expenditure on pet insurance in the region.

    Asia Pacific is estimated to upscale at the fastest CAGR in the global veterinary laboratory testing market over the assessment period. This can be owed to the rising awareness towards the use of sterile consumables for lab-testing and mounting healthcare expenditure in the region.

    Veterinary Laboratory Testing Market Key Players

    The report by MRFR has profiled some distinguished market players in the global veterinary laboratory testing market. Some of these key players include Abaxis, Inc., Biomérieux SA, BIOCHECK Inc., Henry Schein, Inc., Idexx Laboratories, Heska Corporation, Idvet, Pfizer, Neogen Corporation, Qiagen N.V., Thermo Fisher Scientific, Randox Laboratories, Ltd., Virbac, VCA Inc., and Zoetis, Inc.

    Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/veterinary-laboratory-testing-market-7326

    Veterinary Laboratory Testing Industry Update

    July 2019: LexaGene Holdings, Inc. recently announced results from its first beta prototype placed at the Massachusetts Veterinary Referral Hospital. These results were found to be more than 98% concordant, as per the laboratory-generated report.

     


  • COVID 19 Analysis: ADME Toxicology Market: 2020 Global Sales, Size, Share And Key Players

    ADME Toxicology Market Insights

    According to the reports published by Market Research Future, the global ADME toxicology market has an alluring growth graph which is recorded to be 11.4% CAGR. Such a growth pattern of the market is triggered by rising application of ADME toxicology, where it is unified for describing absorption, distribution, metabolism, and excretion properties of drug molecules. The system is aided with highly cohesive software, which is used for sample testing. It provides accurate toxicity test and results for the drug development and biopharmaceutical production.

    ADME Toxicology Market: Drivers & Trends

    The vital factor responsible for influencing the growth of ADME toxicology market is the intensifying use of ADME toxic testing by leading pharmaceuticals and biotechnology companies, and growing concerns over the application of animals in clinical trials have aided the growth of the toxicology testing market.

    Apart from this, more key factors influencing the growth of global ADME toxicology market are enhancing the accuracy and predictability of ADME technology that has been derived. This factor is making the market shift towards in-vitro assays for toxicological studies along with increasing global adoption of ADME toxicology testing instruments and systems. These toxicology testing procedures assist in effective drug development, which limits or prevents toxic reactions to the body when medicated. Thus, toxicity levels are decided on the results of tests conducted in natural conditions, which represent real-time reactions of the drug to the patient.

    On the flip side, some factors such a lack of in-vitro models to perceive autoimmunity and immune-stimulation are mainly expected to curb the global ADME toxicology market growth during the forecast period.

    Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/6945

    ADME Toxicology Market Segmentation

    According to Market Research Future, the global ADME toxicology testing market is segmented based on method, technology, application, and end-user.

    By the mode of the method, the market is categorized into the cellular assay, biochemical assay, in silica, and ex-vivo.

    By the mode of technology, this market segment is categorized into cell culture, high throughput, molecular imaging, and OMICS technology.

    By the mode of application, the market has been segmented into systemic toxicity, renal toxicity, hepatotoxicity, neurotoxicity, and others.

    By the mode of end-user, the market is segmented into hospitals and clinics, diagnostic centers, pathological labs, and others.

    ADME Toxicology Market Regional Outlook

    Regionally, the global ADME toxicology testing market has covered the main regions of the Americas, Europe, Asia-Pacific, and the Middle East and Africa.

    It has been projected that the Americas leads the global ADME toxicology testing market owed to the evolution in the North America region, which is chiefly attributed to an increase in research funding, growing awareness about the profits of ADME toxicology testing for commercial industries, and high adoption of toxicology testing in research. These factors have cumulatively influenced the growth of the market in this region.

    Europe is the second largest region in the ADME toxicology testing market share owing to the high acceptance of toxicology testing in research. Also, the development in research expenditure is responsible for the growth of ADME toxicology testing market. The regional report also mentions that in January 2014, Cyprotex PLC, a UK based company signed an acquisition agreement with CeeTox, Inc. for its business to expand its portfolio for in-vitro toxicity tests and screening services to the Cosmetics and Personal Care Industry.

    Whereas, Asia-Pacific was projected to be the fastest growing region for the global ADME toxicology testing market in 2017 with factors such as increased efforts for the development of new diagnostic devices and adoption of modern technologies to improve the standard of diagnostics assays being supplied. Countries such as China and Japan are crucial that are contributing to market growth. Even the Middle East and Africa hold the least share in the global ADME toxicology testing market owing to the occurrence of underprivileged health expenditure and economically diverse countries. However, the market is expected to observe growth with increasing toxicology care programs in the Middle East.

    Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/adme-toxicology-testing-market-6945

    ADME Toxicology Market Key Players

    The key players in the global ADME toxicology testing market are Promega Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc.,  Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Cellartis AB, Cyprotex PLC., Life Technologies Corporation, Optivia Biotechnology, Inc., Accelrys, Inc., Molecular Discovery Ltd., Cyprotex PLC, MultiCASE, Inc., Caliper Life Sciences, Inc., Xceleron, Inc., ACEA Biosciences, Inc., Albany Molecular Research, Inc., CeeTox, Inc., and others.


  • COVID 19 Analysis: Digital X-rays Market Key Players, Demand, Growth, Applications

    Digital X-rays Market Analysis

    Digital x-ray is associated with the benefits of improved image quality, ease of equipment handling, image throughput, and most importantly, the ability to provide real-time results due to which they have gained widespread adoption among healthcare institutions. Market Research Future (MRFR) has analyzed the global; digital x-rays market to be a growing market which is anticipated to showcase substantial growth over the forecast period of 2018-2023. Demand for efficient diagnostic technologies coupled with expanding healthcare budget across the globe has significantly driven the digital x-rays market. Chronic diseases are spreading at an alarming rate due to changing lifestyle and dietary habits which induce substantial demand for effective diagnostic methods for proper treatment. Other factors include government initiatives towards the modernization of healthcare sector and rise in the global aging population.

    Advancements in digital x-ray techniques, detector technology, digital image storage, and computer-aided detection have revolutionized the process of image acquisition and substantially led to the consolidation of the global digital x-rays market. Increase in a number of diagnostic centers and hospitals too bodes well for the market growth. The high incidence rate of breast cancer is also a key factor influencing the growth of the market. Growing concerns related to breast cancer has spurred the demand for breast cancer screening or mammography. The prevalent trend of procuring the latest technologies by the healthcare sector is also creating a favorable environment for the growth of the market. Furthermore, as market players are endeavoring to strengthen business capabilities, they are investing heavily in new product launches.  On the contrary, the growth of the global digital x-rays market might be hindered by high-cost low healthcare penetration in certain regions and high costs of digital x-rays which restrict market growth in price-sensitive markets. 

    Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/6579

    Digital X-rays Market Segmentation

    The global digital x-rays market has been segmented based on application, technology, portability, and end user. 

    By application, the global digital x-rays market has been segmented into general radiography, dental applications, mammography, and fluoroscopy. 

    By technology, the global digital x-rays market has been segmented into computed radiography and direct radiography. 

    By portability, the global digital x-rays market has been segmented into fixed digital X-ray systems and portable digital X-ray systems. 

    By end user, the global digital x-rays market has been segmented into diagnostic centers and hospitals. 

    Digital X-rays Market Regional Analysis

    By region, the global digital x-rays market has been segmented into Europe, Asia Pacific (APAC), North America, and the Rest of the World (RoW). 

    North America is domineering the global digital x-rays market. Robust healthcare sector, high expenditure on healthcare infrastructure, and the tendency to adopt latest technologies boost the growth of the North America market. Favorable reimbursement scenario in the region also works in favor of market growth.

    APAC is a significant market for digital x-rays which is likely to exhibit rapid growth over the forecast period. Expanding healthcare budgets, increasing disposable income, and increasing automation in the healthcare sector drives the APAC digital x-rays market. Increase in geriatric population and government initiatives towards the modernization of the healthcare sector creates a conducive environment for the growth of the market.

    Europe market is driven by rising demand for automated healthcare services and augmented R&D activities for ten development of highly efficient medical devices by the market players in the region. 

    Digital X-rays Market Competitive Landscape

    GE Healthcare, Seimens AG, Philips Healthcare, Hitachi Medical Corporation, Samsung Medison Co. Ltd., Shimadzu Corporation, Koninklijke Philips N.V.,Toshiba Medical Systems Corporation, Fujifilm Corporation, Carestream Health, Konica Minolta Inc., Canon Inc. are the key players in the global digital x-rays market. 

    Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/digital-x-rays-market-6579

    Digital X-rays Industry Updates

    In January 2019, LG, a South Korean electronics company, launched an innovative range of medical imaging solutions for diagnostics at the Arab Health. The new digital imaging system offers greater ease of use and accuracy; is dust and waterproof. It is equipped with 5:4 aspect ratio and wide viewing capabilities, digital X-ray detector and diagnostic monitor with color calibration and display accuracy.

     


  • COVID 19 Analysis: Absorbable Surgical Sutures Market: Business Opportunities, Size, Growth

    The increasing cases of grievous wounds due to accidents has led to the development of absorbable surgical sutures. Absorbable surgical sutures are medical devices designed to be absorbed into the body after the healing of the wound. The global absorbable surgical sutures market report by Market Research Future (MRFR) highlights trends, drivers, and opportunities compiled from historical data and current events.

    Absorbable Surgical Sutures Market Overview

    The global absorbable surgical sutures market is expected to generate considerable revenues for the period between 2018 and 2023 (forecast period) due to rise in the cases of injuries to soft tissues and skin. The notable increase in peripheral vascular surgery can bode well for the market growth till 2023. Increasing rate of musculoskeletal diseases and the rising rate of the elderly populace can influence its demand by a considerable amount. Low chances of wound infection is one of the primary driving factors of hospitals and clinics adopting absorbable surgical sutures.

    The efficacy shown by these sutures in major surgeries can bode well for the market till the end of the forecast period. Changing government regulations for surgical procedures as well as availability of treatment options for boomers can bode well for the market. Awareness of the product in emerging regions can present favorable growth opportunities to the players. The use of surgical anastomosis by doctors for creating a connection between tubes or blood vessels can magnify the demand for absorbable surgical sutures.

    Absorbable Surgical Sutures Market Segmentation

    The global absorbable surgical sutures market has been segmented on the basis of type, structure, application, and end-user.

    On the basis of type, the market has been classified as synthetic and natural sutures. Synthetic sutures have been segmented into poliglecaprone suture (Monocryl), vicryl, and polydioxanone suture (PDS). Natural sutures have been segmented into collagen, catgut suture, and polyglycolic acid suture. Among synthetic, the PDS segment can command a high market demand due to its high tensile strength and extended wound support.

    On the basis of structure, the market has been classified as monofilament and multifilament sutures.

    Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/6363

    On the basis of application, the market has been classified as general surgery, cardiovascular surgeries, gynecological surgeries, orthopedic surgeries, and other surgeries.

    On the basis of end-users, the market has been classified as hospitals, clinics, ambulatory surgery centers, and others. The high volume of surgeries and first step in emergency care are likely to spike its demand among hospitals, ambulatory surgery centers, and clinics. Sutures are sterilized and safe for prolonged use and will witness high demand in the forthcoming years.

    Absorbable Surgical Sutures Market Regional Analysis

    On the basis of region, the Absorbable Surgical Sutures Market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa (MEA).

    North America is expected to dominate the market due to the region being an early adopter of latest medical technologies. The rising number of chronic diseases, rate of surgical procedures, and approval granted by federal agencies are factors driving the market growth.

    The MEA region can exhibit a tremendous growth rate during the forecast period due to large number of countries investing sufficient funds to improve their healthcare infrastructure. Technological advances in the manufacturing process is likely to spell good fortunes for the market in the region. Development of the medical devices with polymers such as polylactic acid, polydioxanone, and polyester can augur favorably for the global absorbable surgical sutures market.

    Absorbable Surgical Sutures Market Competition Outlook

    Key players of the market include Smith & Nephew plc, 3M Healthcare, B. Braun Melsungen AG, W.L. Gore & Associates, Internacional Farmaceutica, S.A. de C.V., Ethicon Inc., EndoEvolution, LLC, Johnson & Johnson Private Limited, Sutures India Pvt. Ltd., Medtronic plc, Conmed Corporation, Boston Scientific Corporation, Péters Surgical, and DemeTECH Corporation.

    Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/absorbable-surgical-sutures-market-6363


  • COVID 19 Analysis: Angiography Equipment Market Segmentation, Market Players, Trends

    Angiography Equipment Market Overview

    The prevalence of cardiovascular and coronary diseases is rising continually over the past few years, and changing lifestyle is the primary reason. The good news is that there are several novel treatment procedures and equipment & devices are available in the market for the management of these conditions. The drastic increase in the numbers of angiography procedures performed every year is driving the demand for equipment and devices to be used during these procedures. 

    Resultantly, the size of the angiography equipment market is on a constant rise. Also, equipment used in angiography procedures has evolved significantly, demonstrating remarkable advances. Such betterments are driving the growth of the market, predominantly. Moreover, a noteworthy increase in the awareness about the availability of cardiovascular-related surgeries and treatments accelerates market growth.

    Acknowledging the significant traction that the market is garnering currently, a leading research firm - Market Research Future (MRFR) asserts that the global angiography equipment would further witness substantial growth by 2023. In its recently published analysis, MRFR also states that during the assessment period (2018-2023), the market would post a CAGR over 5%. Technological advancements in interventional radiology is a key driving force behind the growth of the market.

    The growing demand for interventional angiography systems driven by the increasing numbers of minimally invasive surgeries along with the rising healthcare expenditures defines the growing landscape of the market. In addition to the increasing prevalence of cardiovascular diseases and increasing numbers of angiography procedures, advancing techniques benefitting in early diagnosis & treatments also act as significant growth propellers. 

    Conversely, significant factors hampering the growth of the market are limitations in reimbursement for angiographic surgeries and risk of radiation exposures. However, improving economic conditions would support the market growth over the assessment period, increasing the access to the quality care and per-capita healthcare expenses.  

    Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/6106

    Global Angiography Equipment Market   - Segments

    The analysis is segmented into seven market dynamics to widen the scope of understanding,

    By Procedure          :  Endovascular Angiography, Coronary Angiography, Neuro-Angiography, Onco-Angiography, and other Angiography Procedures.

    By Technology        :  CT angiography, X-ray angiography, MR angiography, and other angiography technologies.

    By Product               : Angiography Catheters, Angiography Systems, Angiography Contrast Media, Angiography Balloons, Vascular Closure Devices (VCDs), Angiography Guidewires, and Angiography Accessories.

    By Indication          : Valvular Heart Disease, Coronary Artery Disease, Congenital Heart Disease, Congestive Heart Failure, and other indications.

    By Application       : Diagnostics and Therapeutics.

    By End-user             : Hospitals & Clinics, Diagnostic & Imaging Centers, and Research Institutes.

    By Regions              : Europe, North America, Asia Pacific, and the Rest-of-the-World. 

    Global Angiography Equipment Market - Geographical Analysis

    The European region dominates the global angiography equipment market with the largest market share. The increasing healthcare expenditures and the growing population in the region are some of the factors that act as a major tailwind pushing the regional market forward. Moreover, the presence of well-developed healthcare infrastructure and a large patent population suffering from cardiovascular disorders spur the regional market growth.

    Moreover, spreading awareness of CABG procedures and technological advancements are expected to support the angiography equipment market in the region. Also, increasing numbers of angiography surgeries and the growing preference for minimally invasive procedures contribute to the growth of the regional market. Furthermore, the rising prevalence of cardiovascular diseases increases the demand for angiography equipment in the increasing numbers of specialty care services in hospitals & tertiary care centers in the region. 

    The angiography equipment in North America takes the second leading position, globally, witnessing increasing numbers of coronary artery bypass procedures. Growing geriatric population and the prevalence of cardiac diseases drive the regional market growth, majorly. Additionally, increasing expenditure on healthcare alongside the well-developed healthcare sector impacts the growth of the North American angiography equipment market.  

    Moreover, high per capita healthcare spending and the growing prevalence of coronary diseases in the region spur the market growth in the region. The presence of state-of-the-art-infrastructure contributes to the regional market, allowing the development of technologies and the early adoption of advanced technologies. Furthermore, the rapid uptake of advanced technologies and devices in the surgical process is a key growth driving factor. 

    The angiography equipment market in the Asia Pacific region is emerging as a promising market globally. The region witnesses rising cases of patients suffering from cardiovascular disease and coronary diseases. Besides, the proliferating healthcare sector in highly populated countries like India, Japan, and China drive regional market growth. 

    Additionally, a large patient population alongside, the rising investments by private and public sectors fosters the growth of the regional market. Also, increasing geriatric populace and spreading awareness about healthcare, positively influence the growth of the regional market. 

    Angiography Equipment Market - Competitive Landscape

    Highly competitive, the angiography equipment market appears fragmented due to the presence of many well-established players. To gain a large share in the market, players adopt strategies such as mergers & acquisitions, collaboration, expansion, and product & technology launch. Substantial investments are transpired in R&D to bring betterment in the existing products as well as to develop new ones. 

    Angiography Equipment Market Major Players: 

    Players churning the competition in the global angiography equipment market include Koninklijke Philips N.V. (Netherlands), Siemens Healthineers (Germany), GE Healthcare (US), Boston Scientific Corporation (US), Cordis, a Cardinal Health Company, (US), Canon Corporation (Japan), Medtronic (Ireland), Angiodynamics (US), Shimadzu Corporation (Japan), Abbott Laboratories (US), Terumo (Japan), and B. Braun Melsungen (Germany), among others. 

    Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/angiography-equipment-market-6106

    Angiography Equipment Industry/Innovation/Related News:

    September 02, 2019 --- Garrison Financial Corporation (the US), a leading provider of investment advisory services announced the acquisition of additional 6,527 shares in Abbott Laboratories (the US), a health care company involved in the development and sales of a broad and diversified line of health care products and services. It is an increase of 8.8% stake of the company after ABT’s stock rose 10.62%.

    Garrison Financial’s portfolio includes wealth management, equities, fixed income, investment strategies, financial planning, consulting, and advisory services. Abbott Laboratories’ products include pharmaceuticals, nutritional, diagnostics, and vascular products. The company markets its products worldwide through affiliates and distributors. In April last year, Abbott had initiated a groundbreaking study to assess the superiority of high-resolution imaging versus standard-of-care angiography in T. 


  • COVID 19 Analysis: Cough Syrup Market Analysis, Growth Prospects Predicted By 2026

    Cough Syrup Market Analysis  

    The global cough syrup market is anticipated to touch USD 5,139.63 million at a 3.45% CAGR between 2014-2026, states the new Market Research Future (MRFR) report. Cough syrups, simply put, are medications that are used to offer temporary relief from a runny nose, sneezing, and coughs due to hay fever, common cold, and other types of respiratory allergies. There are various forms of cough syrups available in the market resting on when it is taken. Daytime cough syrups do not have codeine, which means it will not make one feel drowsy. On the other hand, nighttime cough syrups contain codeine. They last longer compared to daytime cough syrups, thus allowing better sleep at night. Most importantly, cough medicines cannot be taken by people with heart disease or high blood pressure, and those who are taking SSRI antidepressants.  

    Numerous factors are adding to the growth of the global cough syrup market. These factors, according to the latest Market Research Future report, include increasing product developments, a rise in geriatric pollution, increasing income in developing economies, massive air pollution, and an increase in respiratory disorders.  

    On the contrary, the availability of substitutes, stringent regulatory scenario, and product recalls are factors that may restrict the global cough syrup market growth during the forecast period.  

    Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/8217

    Cough Syrup Market Segmentation 

    The Market Research Future report provides a complete segmental analysis of the global cough syrup market based on application, category, and type. 

    By type, the global cough syrup market is segmented into individuals and combinations. The individual segment is again segmented into codeine, ambroxol, guaifenesin, and dextromethorphan. The combination segment is again segmented into brompheniramine + pseudoephedrine, guaifenesin + pseudoephedrine, and dextromethorphan + guaifenesin. 

    By category, the global cough syrup market is segmented into expectorants and suppressants.  

    By application, the global cough syrup market is segmented into children and adults.  

    Cough Syrup Market Regional Analysis 

    By region, the global cough syrup market report covers the latest trends and growth opportunities across the Americas, Europe, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will dominate the cough syrup market during the forecast period. It is projected to grow at a 3.16% CAGR. Numerous factors are adding to the growth of the global cough syrup market in the region such as the availability of advanced medicines to treat chronic obstructive pulmonary disease (COPD), rising prevalence of respiratory disorders, strategic acquisitions by key players to augment product portfolio, and presence of leading players in the region.  

    Europe will hold the second-largest share in the cough syrup market during the forecast period for the presence of top players in the region, such as Reckitt Benckiser Group PLC, GlaxoSmithKline, and Novartis. Besides, the booming pharmaceutical industry in the UK, France, and Germany are also adding to the market growth.  

    The global cough syrup market in the APAC region will grow at the fastest pace during the forecast period. Numerous factors are adding to the growth of the global cough syrup market in the region such as constant development in China as well as India, rising incidence of respiratory diseases on account of exposure to air pollution in the workplace and home, tobacco smoke, indoor air pollution from various biological agents associated with mold and damp, and vehicular pollution.  

    The global cough syrup market in the Middle East and Africa will have notable growth during the forecast period. Numerous factors are adding to the growth of the global cough syrup market in the region, such as increasing healthcare expenditure, growing per capita disposable income, and advancing healthcare infrastructure. Saudi Arabia and the UAE are the leading contributors in this region. Africa is a less developed region having limited facilities and healthcare resources for the people. This low growth rate is on account of less efficient and less developed health systems.  

    Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/cough-syrup-market-8217

    Cough Syrup Market Key Players 

    Notable players profiled in the global cough syrup market report include Sanofi (France), Abbott (US), Reckitt Benckiser Group PLC (UK), Procter & Gamble (US), Acella Pharmaceuticals, LLC (US), GlaxoSmithKline PLC (UK), Johnson & Johnson Services, Inc. (US), Merck KGaA (US), Novartis AG (Switzerland), and Pfizer, Inc. (US). 

     


  • COVID 19 Analysis: Hemoglobinopathies Market Expected To Grow At CAGR Of 10.2% By 2025

    Hemoglobinopathies Market Overview: 

    Market Research Future (MRFR) recently revealed that the global hemoglobinopathies market is making significant progress from its previous valuation of USD 5800 million in 2018 and in the forecast period of 2019 to 2025, it could reach a 10.2% CAGR. The report also included several factors like growing patient awareness regarding the disease, increasing market contributions made by various players and governments to boost the research funding, the inclusion of top-class technologies, the growing prevalence of diseases like thalassemia, and others can boost the global market surge.  

    However, this growth can be deterred by unhygienic and poor healthcare structures in various developing and underdeveloped regions.  

    Hemoglobinopathies Market Segmentation: 

    The global hemoglobinopathies market report has several segments like treatment, type, and end users. These segmental studies are loaded with various figures gathered from an understanding of the factors and market dynamics. A close analysis of these would ensure better market understanding and would assist in better development of strategies.  

    By type, the global market for hemoglobinopathies can be segmented into sickle cell disease, thalassemia, and other Hb variant diseases. The Thalassemia segment further encompasses alpha-thalassemia and beta-thalassemia. The sickle cell disease segment has the opportunity to control the largest market share. 

    Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/8098

    By treatment, the global study of the market includes blood transfusions, analgesics, stem-cell transplantation, ACE inhibitors, antibiotics, and hydroxyurea. The blood transfusion segment is controlling a substantial part of the global market as its reach is penetrating in several associated treatments.  

    By end user, the global market for the hemoglobinopathies can be segmented into diagnostics laboratories, hospitals and clinics, and others. The hospitals & clinics segment would gain traction as their superlative infrastructure and demand from patients back up the growth. 

    Hemoglobinopathies Market Regional Analysis: 

    The Americas has the opportunity to control the global market as the regional market is fetching the maximum market revenue. This region would benefit from the presence of countries like the US and Canada in the northern part. Their superlative infrastructure would help the market in ensuring decent growth. At the same time, a high number of sickle cell disease patients would influence market growth. In Europe, this growth in the market would be similar. Both these regions are expected to garner revenues by launching latest innovations to speed up processes and increasing their research-related funding. In the Asia Pacific region, overhauling healthcare structures in several countries could boost global growth. Growing awareness regarding several diseases associated with the therapies and increasing funding from government and private bodies are expected to promote growth. In addition, top players are targeting the region to explore various growth possibilities and expand their business.  

    Hemoglobinopathies Market Competitive Landscape: 

    The global market for hemoglobinopathies depends on various strategic details launched by eminent players like Global Blood Therapeutics, Bluebird Bio Inc., Sanofi, Sangamo Therapeutics Inc., Prolong Pharmaceuticals, Emmaus Life Sciences Inc., Alnylam Pharmaceuticals, Gamida Cell, Celgene Corporation, Mast Therapeutics, HemaQuest Pharmaceuticals, Acceleron Pharma, and Invenux. These market players are making notable contributions by launching several tactics like mergers, acquisitions, increasing investments in research and development facilities, and others. MRFR’s listing highlights recent moves to facilitate understanding of the market progress.  

    Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/hemoglobinopathies-market-8098

    Hemoglobinopathies Industry News: 

    In March 2020, IMARA Inc. announced the pricing of their 4,700,000 shares, which they would soon launch. The company has made a name for itself in the pharmaceutical sector by developing drugs to combat hemoglobin disorders. The novel therapies used for the treatment are known as hemoglobinopathies and the company has substantial expertise in such endeavors. 


  • COVID 19 Analysis: Medical Device Connectivity Market Estimated To Lock An Ineffaceable Growth

    Medical Device Connectivity Market Overview

    The increased saturation rates achieved by electronic health records is expected to galvanize the development of the medical device connectivity market. Reports that assess the Healthcare IT industry have been presented by Market Research Future, which creates reports on numerous industry verticals that examine the market progress and forecasts. The market is poised to attain a CAGR of 16.1% roughly in the duration of the forecast period.

    The expansion of health information exchange systems in healthcare organizations is creating a favorable impetus for the expansion of the medical device connectivity market.  Furthermore, the infiltration of EHRs via the partnership between IT service contributors and healthcare service suppliers. The development of a unified platform to generate uniformities by the reorganization of physician workflows is expected to unlock increased growth potential for the market in the impending years.

    Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/6041

    Medical Device Connectivity Market Segmental Analysis

    The segmental assessment of the medical device connectivity market is carried out on the basis of technology, products, and services, region, and end-user. On the basis of products and services, the market for medical device connectivity is segmented into medical device connectivity services and medical device connectivity solutions. On the basis of technology, the market for medical device connectivity is segmented into wireless technologies, wired technologies, and hybrid technologies. Based on end-user, the medical device connectivity market is segmented into home healthcare, hospitals, diagnostic centers, ambulatory care centers, and others. By region, the medical device connectivity market is segmented into the Asia Pacific, the Americas, the Middle East, Europe, and Africa.

    Medical Device Connectivity Market Regional Analysis     

    The regional assessment of the medical device connectivity market includes regions such as the Asia Pacific, the Americas, the Middle East, Europe, and Africa. The North American region’s medical device connectivity market has been the primary choice for the deployment of medical device connectivity solutions owing to the presence of a well-known healthcare system and technology improvements. The European region holds the subsequent principal market segment. The progress of the region is accredited to the growing use of medical device connectivity solutions and services, which raises the efficiency of the healthcare workforce and systems. The Asia Pacific region is anticipated to develop at a quicker pace throughout forecast period due to a huge number of emerging countries such as India and Malaysia, among others which are progressively deploying medical device connectivity solutions for better healthcare and instructing people about awareness. On the other hand, the Middle East and African region possesses the lowest market segment of the medical device connectivity market, owing to reduced accessibility to funds and restricted availability of medical facilities which are extra in regions such as Europe, the Americas, and the Asia Pacific.

    Medical Device Connectivity Market Competitive Analysis

    The growth of the market is influenced by the presence of factors that are stimulating the growth of the market. The need to create a sustainable competitive advantage has accelerated the progress of the market in the forecast period. The diversified consumer tastes and trends in the market are anticipated to lead to an escalated development rate in the market. The use of strategic tools to further the development of the market in the coming years. The competitors have adopted diversified plans to increase their chances for success in the market. The creation of great competitive advantages is expected to aid in the development of the market. A substantial ascent in the number of promoters in the market is anticipated to shape a beneficial state of activities for the growth of the market in the forecasted period. The access to vital planned prospects imperative to the resultant stabilization of inflation is likely to produce a promising option for advancement in the forthcoming years.

    Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/medical-device-connectivity-market-6041

    The noteworthy contenders in the medical device connectivity market are Cerner (U.S.), Qualcomm (U.S.), GE Healthcare (U.S.), Bernoulli Enterprise (U.S.), Medtronic (U.S.), Koninklijke Philips N.V. (Netherlands), Cisco Systems (U.S.), Infosys (India), Nanthealth (U.S.), Lantronix (U.S.), Ihealth Lab (U.S.), Nuvon, Inc, True Process (U.S.), Stryker Corporation, eDevice, Inc., and others.

     

     


  • COVID 19 Analysis: Surgical Equipment Market Estimated To Grow With A Healthy CAGR By 2023

    Market Research Future (MRFR) collected data on several factors including implications of COVID 19 Impact on Surgical Equipment Market and demographic challenges, showed how it could move forward in the coming years.

    Surgical Equipment Market Analysis

    According to Market Research Future (MRFR, the global surgical equipment market is anticipated to acquire a significant valuation at a 6.2% CAGR during the forecast period.

    The global surgical equipment market is influenced positively by the rising prevalence of chronic diseases such as cardiovascular diseases, obesity, skin diseases, among others. Additionally, the increasing number of surgeries in ambulatory surgical centers and hospitals, coupled with rising geriatric population globally is also likely to impact the market over the review period. moreover, the growth of the medical device market, a growing number of surgical centers, and government initiatives have a positive impact on the market. on the other hand, the growth of the market is restricted by various factors such as the high cost of healthcare surgical devices and stringent regulatory policies from multiple governmental authorities across the globe.

    Surgical Equipment Market Segmental Analysis

    The global surgical equipment market is segmented based on product type, application, and end-user.

    The several types of products available in the global surgical equipment market are electrosurgical devices, electrosurgical generators, handheld instruments, monitoring devices, surgical sutures and staplers, and others. Surgical sutures and staplers segment is sub-segmented into absorbable and non-absorbable sutures. The handheld instruments segment is sub-segmented into forceps, sutures, visual scope, and others. The electrosurgical devices segment is sub-segmented into electrosurgical instruments such as electrosurgical generators, HET bipolar system, electrosurgical pencils, smoke evacuation system, and others. The applications of surgical equipment are cardiovascular surgeries, neurosurgery, orthopedic surgery, urology, wound closure, and others. On the basis of end-user, the surgical equipment market is segmented into ambulatory surgical centers, hospitals, and others.

    Surgical Equipment Market Regional Analysis

    Based on the region, the global surgical equipment market is segmented into the Americas, Asia Pacific, Europe, and the Middle East and Africa.

    The Americas accounts for the largest market share of the global surgical equipment market over the review period. The growth of the global medical device sector, rising emphasis on quality medical care, and the accessibility of advanced surgical devices are the essential drivers for the market growth. North America accounts for the largest market share among the americas, with the U.S. and Canada being the foremost contributor to the growth of the market. In the U.S., the presence of significant market players in the medical device industry and the extensive usage of advanced surgical devices is likely to drive the market over the review period. South America also exhibits a vast scope of growth opportunities with an increase in the demand for surgical devices in the forecast period.

    Europe is also considered a significant region in the global surgical equipment market and is likely to follow behind North America in terms of market share over the review period. France, Germany, and the U.K. are the major contributors to the market growth. The rising number of market players producing surgical equipment, increasing government support, and a rise in outpatient surgeries are expected to fuel the market growth in the European nations. moreover, growing healthcare expenditure by European governments is also expected to create favorable factors for market growth.

    The Asia Pacific region is the fastest-growing region in the global surgical equipment market, owing to the massive demand for surgical devices and instruments, growing awareness about quality medical care in hospitals and surgical centers, and the rising prevalence of chronic diseases such as cardiovascular diseases in the region. India, china and Australia are the major contributors to the market owing to the availability of skilled medical professionals and growing healthcare expenditure by the governments of these countries over the review period.

    In the Middle East and African region, the market growth of the surgical equipment market in the region is expected to be gradual over the review period and is attributed to the growing accessibility of specialty healthcare services in middle eastern developing countries such as the United Arab Emirates and Saudi Arabia. The African region is expected to exhibit a steady growth owing to the demand for primary healthcare services in the region.

    Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/surgical-equipment-market-556

    Surgical Equipment Market Key Players

    The key players identified by MRFR in the global surgical equipment market are B. Braun Melsungen AG (Germany), CONMED Corporation (US), COVIDIEN (US), Erbe Elektromedizin GmbH (Germany), Ethicon US, LLC. (US), Integra LifeSciences Corporation (US), KARL STORZ & Co. (US), KLS Martin (Germany), MEDICON (US), Smith & Nephew (UK), Stryker Corporation (US), and Synergetics USA, Inc. (US).


  • US Personalized Medicine Market 2020 Development Strategy, Sales Revenue, Key Vendors

    Personalized medicine or precision medicine is a novel approach by doctors and clinicians to separate patients on the basis of their response to certain medications. The US personalized medicine market report by Market Research Future (MRFR) compiles a list of trends, drivers, and opportunities which are deemed to predict the value and year-on-year growth rate from 2017 to 2023 (forecast period).

    US Personalized Medicine Market Outlook

    The US personalized medicine market is predicted to gain significant revenue at 7.5% CAGR over the forecast period due to pharma and biotechnology companies turning to personalized medicines to improve the accuracy and potency of the drug. Policies designed to reform the testing, development, marketing, and prescription of drugs and medicines for safe use by customers is likely to define the U.S. market.

    High prevalence of cancer cases is expected to be one of the biggest drivers of the regional market. This is buttressed by the World Health Organization (WHO) report of 2017, which pegs cancer related deaths in the U.S. to amount to 17.5 million. Targeted medicine or theranostics aim to increase the efficacy of the medicine by specifically targeting the site of the tumor. Moreover, approval of companion diagnostics and biomarker products driven by successful clinical trials can work in favor of the market.

    Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/2937

    US Personalized Medicine Market Segmentation Analysis

    The U.S. personalized medicine market is segmented by product, application, and end-user.

    By product, the market is segmented into nutrition and wellness, therapeutics, medical care, and diagnostics.

    By application, the market is segmented into cancer genomics, drug development and usage, diagnosis and intervention, and others. The cancer genomics segment accounted for close to 30% market share in 2016, followed by diagnosis & intervention, drug development and usage, and others. This can be attributed to the use of genomic technologies for analyzing the seriousness of tumor samples and developing biomarkers capable of sufficient resistance.

    By end-user, the market is segmented into bio and health informatics companies, molecular diagnostic laboratories and testing centers, academic institutes, hospitals, and others.

    US Personalized Medicine Market Regional Analysis

    The U.S. personalized medicine market is expected to expand continuously in size due to the large healthcare expenditure accorded by the government and huge pool of cancer patients. Technological breakthroughs in diagnostic tests and liquid biopsy can bode well for the market over the forecast period. In addition, the inclination of the elderly towards personalized medicine can open the floodgates for the industry. However, the younger populace with high level of awareness can also bode well for the regional market.

    US Personalized Medicine Market Competitive Outlook

    GE Healthcare, Bristol-Myers Squibb, Abbott, CardioDx Inc., Laboratory Corporation of America, Pfizer Inc., Siemens Healthcare Diagnostics Inc., Asuragen Inc., Becton Dickinson & Co., Quest Diagnostics, Sanofi, and others are some of the prominent manufacturers in the market.

    US Personalized Medicine Industry News

    The Blue Shield of California has launched its own wellness platform for members to achieve their individual goals. The data acquired can give the company insights to cater to patients and their specific needs. The metrics can assist doctors in prescribing the right medicine and dietary programs as well as new areas for the personalized medicine to expand in the coming years. The company has partnered with Solera Health, an online application for chronic disease management platform.

    Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/personalized-medicine-market-2937

    Wearables which are becoming common among the populace can hold the key to trigger the next development in precision medicine. Physiological and biochemical sensors within these devices can record useful data of customers for registering alcohol and glucose levels and be used for clinical use. Concerted effort by clinicians and doctors can rely on the data for creating an foolproof approach towards patient care.


  • COVID 19 Analysis: Scoliosis Treatment Market Research Report – Forecast To 2025

    Scoliosis Treatment Market Overview

    Global Scoliosis Treatment Market is expected to register a CAGR of ~ 3.9% during the forecast period of 2019 to 2025 with a market value of USD 2,580.2 million in 2018.

    Scoliosis is an abnormal curvature of the spine that can occur in growing children during growth spurt just before puberty. Though the exact cause for scoliosis is not known, in many cases it has been caused by conditions such as muscular dystrophy and cerebral palsy. Depending on the severity of the curve and the risk for it getting worse, scoliosis can be treated with observation, bracing, or surgery. It is one of the most common types of spinal deformities and in the United States, total number of scoliosis cases is estimated to be more than 4 million. Nearly 29,000 scoliosis surgeries are performed on adolescents every year in the U.S. 

    Treatment for scoliosis includes wearing back braces and in severe cases spinal surgery. While in many cases where the scoliosis is not very severe a back brace is worn that can be removed for activities like showing, in more complicated cased, rods are placed inside the body which have to be extended every 6 months in growing children. As such cases can be quite traumatic for some patient, innovation in the scoliosis treatment industry has witnessed the introduction of MAGEC rods that are different from traditional rods as they can be magnetically lengthened without any surgery.

    Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/8230

    Scoliosis Treatment Market Segmentation:

    The scoliosis treatment market classification includes disease, product and distribution channel.

    As a disease, scoliosis treatment market can be segmented as infantile idiopathic scoliosis and adolescent idiopathic scoliosis.

    On the basis of product, scoliosis treatment market has been divided as thoracic, lumbarsacral orthosis (CTLSO), cervical, lumbosacral orthosis (LSO) and thoracolumbosacral orthosis (TLSO).

    The distribution channel segment has been segregated into hospitals & clinics, retail pharmacies, and online pharmacies.

    Scoliosis Treatment Market Regional Analysis:

    Geographically, scoliosis treatment market is segmented into North America, Europe, Asia-Pacific and Middle East & Africa.

    The Americas scoliosis treatment market is expected to hold a dominating share due to the increasing expenditure on healthcare research, especially in North America. In the U.S. and Canada, increasing per capita income as well as increased expenditure on healthcare and availability of advanced technology are factors that will be responsible for driving the scoliosis treatment market in the region.

    Scoliosis treatment market in Europe is expected to grow at a significant rate due to the presence of a robust healthcare system, strong infrastructure for research and development and presence of critical companies dealing in scoliosis treatment.

    Rising awareness about the condition and its treatment in Asia-Pacific is expected to boost scoliosis treatment market in the region. Increasing government initiatives for a more reliable healthcare system and demand for spine surgeries will help to augment market growth.

    The market in the Middle East & Africa is projected to account for the least share of the global market due to low disposable income in the region.

    Scoliosis Treatment Market Competitive Landscape:

    Some of the prominent players in the scoliosis treatment market are Boston Orthotics & Prosthetics, Chaneco, Charleston Bending Brace, Orthotech, Trulife, Össur, DJO, SPINEFORM LLC, Wilmington Orthotics & Prosthetics Inc., Lawall Prosthetics and Orthotics, Horton's Orthotics & Prosthetics, Aspen Medical Products, UNYQ, C H Martin Company, Optec USA, Inc., Spinal Technology, Inc. Zimmer Biomet Holdings Inc. and NuVasive.

    Scoliosis Treatment Industry News:

    The exact reason for why scoliosis occurs is yet to be determined but researchers have discovered noels means or identifying spinal curvature patterns in younger children that may develop into scoliosis during their adolescence. The finding is significant as it will help in scoliosis prediction, and may lead to development of methods to prevent the potentially disabling condition. However according to the researchers participating in the study, further and detailed research is yet to be undertaken to determine verify the conclusion of the study.

    Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/scoliosis-treatment-market-8230

    Other technological advancements that can potentially augment the growth of the scoliosis market include new imaging technology developed by researchers at Hospital for Special Surgery in New York that will create three-dimensional maps of the spine to help treat patients with scoliosis. At present enrollment of participants is going on for the study that will test accuracy of the camera that will use 3D surface imaging system. The approach is a significant one as it will eliminate the need for patients to be exposed to radiological imaging that most scoliosis patients have to face for many years.


Digital Marketing Specialist at Market Research Future

connect